Cargando…
Findings from a feasibility study of estradiol for hypogonadal women with cystic fibrosis-related bone disease
BACKGROUND: Advancements in therapies for patients with cystic fibrosis (CF) have decreased mortality, leading to increased prevalence of chronic complications including bone disease. CF-related bone disease (CFBD) is characterized by low bone mineral density (BMD) and fragility fractures. Estrogen...
Autores principales: | Wu, Malinda, Tirouvanziam, Rabindra, Arora, Neha, Tangpricha, Vin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375209/ https://www.ncbi.nlm.nih.gov/pubmed/34412687 http://dx.doi.org/10.1186/s40814-021-00897-x |
Ejemplares similares
-
SUN-337 Low Dose Ethinyl Estradiol in Women with Cystic Fibrosis Does Not Preserve Bone Mass
por: Wu, Malinda, et al.
Publicado: (2020) -
SUN-LB72 The Relationship Between Estrogen Exposure and Bone Health in Women With Cystic Fibrosis
por: Arora, Neha, et al.
Publicado: (2020) -
Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density
por: Wu, Malinda, et al.
Publicado: (2020) -
Use of estrogen supplementation is associated with higher quality of life scores in women with cystic fibrosis
por: Wu, Malinda, et al.
Publicado: (2021) -
Correction of the Gene Defect in Cystic Fibrosis: Is It Too Late for Bone?
por: Tangpricha, Vin
Publicado: (2021)